Medicare Enrolled
Dr. Fadi Kayali, M.D.
Internal Medicine · Sarasota, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kayali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kayali? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kayali
Dr. Fadi Kayali is an internal medicine in Sarasota, FL, with 18 years in practice. Based on federal Medicare data, Dr. Kayali performed 259,482 Medicare services across 5,882 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kayali received a total of $21,656 from 105 pharmaceutical and/or device companies across 918 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kayali is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 0% volume in FL$ $21,656 industry payments
Medicare Practice Summary
Medicare Utilization ↗259,482
Medicare services
Top 0% in FL for internal medicine
5,882
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~14,416 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 99,450 | $0 | $4 |
| Nivolumab injection (Opdivo) | 29,980 | $24 | $72 |
| Pembrolizumab injection (Keytruda) | 18,400 | $43 | $137 |
| Oxaliplatin chemotherapy injection | 17,100 | $0 | $12 |
| Denosumab injection (Prolia/Xgeva) | 13,080 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 12,350 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 12,270 | $6 | $23 |
| Iron sucrose injection (Venofer) | 10,800 | $0 | $5 |
| Daratumumab injection (Darzalex) | 10,440 | $37 | $110 |
| Paclitaxel chemotherapy injection | 6,322 | $0 | $2 |
| Dexamethasone injection (steroid) | 3,554 | $0 | $3 |
| Complete blood count (CBC) with differential | 3,443 | $8 | $29 |
| Immune globulin infusion (Gammagard) | 3,416 | $36 | $108 |
| Blood draw (venipuncture) | 3,256 | $8 | $9 |
| Office visit, established patient (30-39 min) | 1,974 | $95 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,590 | $1 | $28 |
| Drug injection, under skin or into muscle | 1,552 | $10 | $69 |
| Contrast dye for imaging (iodine-based) | 1,340 | $0 | $1 |
| Anti-nausea injection (ondansetron/Zofran) | 920 | $0 | $9 |
| Injection, leucovorin calcium, per 50 mg | 914 | $3 | $12 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 849 | $1 | $6 |
| Administration of chemotherapy into vein, 1 hour or less | 629 | $98 | $378 |
| Injection of additional new drug or substance into vein | 624 | $12 | $61 |
| Injection, fluorouracil, 500 mg | 519 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 508 | $47 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 430 | $22 | $84 |
| Injection, carboplatin, 50 mg | 341 | $2 | $41 |
| Office visit, established patient (20-29 min) | 335 | $62 | $239 |
| Injection, magnesium sulfate, per 500 mg | 330 | $1 | $2 |
| Injection, zoledronic acid, 1 mg | 310 | $7 | $69 |
| Injection, diphenhydramine hcl, up to 50 mg | 223 | $1 | $3 |
| Red blood count automated, with additional calculations | 216 | $5 | $20 |
| Administration of chemotherapy into vein, each additional hour | 191 | $22 | $79 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 173 | $16 | $56 |
| Administration of additional new drug or substance into vein, 1 hour or less | 172 | $49 | $178 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 164 | $53 | $206 |
| Infusion into a vein for hydration, each additional hour | 144 | $10 | $42 |
| New patient office visit (45-59 min) | 132 | $121 | $453 |
| Infusion, normal saline solution , 1000 cc | 126 | $2 | $7 |
| Office visit, established patient, complex (40-54 min) | 121 | $140 | $474 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 87 | $3 | $11 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 85 | $15 | $56 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 85 | $17 | $59 |
| Infusion into a vein for hydration, 31-60 minutes | 80 | $24 | $156 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 66 | $126 | $637 |
| Administration of additional new drug or substance into vein using push technique | 65 | $42 | $170 |
| Automated urinalysis | 63 | $2 | $8 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 55 | $135 | $562 |
| Injection of drug or substance into vein | 49 | $28 | $156 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 46 | $1 | $7 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 33 | $24 | $89 |
| Drawing of blood for a medical problem | 26 | $65 | $277 |
| New patient office visit, complex (60-74 min) | 15 | $173 | $585 |
| Red blood count, automated test | 14 | $4 | $10 |
| Ct scan of chest with contrast | 13 | $54 | $344 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 12 | $124 | $467 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
40.3% high complexity
55.9% medium
3.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,656
Total received (2018-2024)
Avg $3,094/year across 7 years
Top 3% in FL for internal medicine
105
Companies
918
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,142 (83.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,456 (11.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,058 (4.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,288
2023$3,177
2022$3,188
2021$2,229
2020$3,303
2019$2,693
2018$2,777
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$2,278
Daiichi Sankyo Inc.
$1,438
Janssen Biotech, Inc.
$1,286
Celgene Corporation
$1,270
E.R. Squibb & Sons, L.L.C.
$1,140
AstraZeneca Pharmaceuticals LP
$1,138
Novartis Pharmaceuticals Corporation
$1,096
AVEO Pharmaceuticals, Inc.
$900
PFIZER INC.
$750
Lilly USA, LLC
$738
Incyte Corporation
$641
Merck Sharp & Dohme Corporation
$457
Merck Sharp & Dohme LLC
$412
Seagen Inc.
$374
ABBVIE INC.
$349
ARRAY BIOPHARMA INC
$336
Teva Pharmaceuticals USA, Inc.
$317
Astellas Pharma US Inc
$302
Gilead Sciences, Inc.
$281
Amgen Inc.
$271
Coherus Biosciences Inc.
$264
Kite Pharma, Inc.
$253
GlaxoSmithKline, LLC.
$253
Exelixis Inc.
$241
GENZYME CORPORATION
$225
Eisai Inc.
$225
JAZZ PHARMACEUTICALS INC.
$190
BeiGene USA, Inc.
$189
Rigel Pharmaceuticals, Inc.
$183
Ipsen Biopharmaceuticals, Inc
$169
Takeda Pharmaceuticals U.S.A., Inc.
$165
EMD Serono, Inc.
$139
Janssen Pharmaceuticals, Inc
$129
Mirati Therapeutics, Inc.
$123
Ethicon US, LLC
$120
Auris Health, Inc.
$117
Inari Medical, Inc.
$115
Alexion Pharmaceuticals, Inc.
$115
Boehringer Ingelheim Pharmaceuticals, Inc.
$104
Taiho Oncology, Inc.
$103
AbbVie, Inc.
$97
Myovant Sciences Inc.
$94
Pharmacyclics LLC, an AbbVie Company
$90
Pharmacyclics LLC, An AbbVie Company
$85
Janssen Scientific Affairs, LLC
$81
AbbVie Inc.
$78
EISAI INC.
$77
Sysmex Inostics Inc
$71
Alnylam Pharmaceuticals Inc.
$68
Sumitomo Pharma America, Inc.
$68
Puma Biotechnology, Inc.
$68
Regeneron Healthcare Solutions, Inc.
$68
Bayer HealthCare Pharmaceuticals Inc.
$62
Agios Pharmaceuticals, Inc.
$60
PORTOLA PHARMACEUTICALS, INC.
$56
Sun Pharmaceutical Industries Inc.
$54
TerSera Therapeutics LLC
$49
SOBI, INC
$46
G1 Therapeutics, Inc.
$46
GE HealthCare
$44
Foundation Medicine, Inc.
$44
Clovis Oncology, Inc.
$40
PharmaEssentia USA Corporation
$39
Deciphera Pharmaceuticals Inc.
$39
Adaptive Biotechnologies Corporation
$37
Aurobindo Pharma USA, Inc.
$37
PUMA BIOTECHNOLOGY, INC.
$37
Kyowa Kirin, Inc.
$37
Bayer Healthcare Pharmaceuticals Inc.
$37
Pharmacosmos Therapeutics Inc.
$35
MorphoSys, US Inc.
$33
Apellis Pharmaceuticals, Inc.
$33
Seattle Genetics, Inc.
$32
Dova Pharmaceuticals
$32
SpringWorks Therapeutics, Inc.
$32
CTI BioPharma Corp.
$31
GT Medical Technologies, Inc
$29
Karyopharm Therapeutics Inc.
$29
Array BioPharma Inc.
$29
ImmunoGen, Inc.
$28
SERVIER PHARMACEUTICALS LLC
$27
INSYS Therapeutics Inc
$27
Epizyme, Inc.,
$26
Lexicon Pharmaceuticals, Inc.
$24
Heron Therapeutics, Inc.
$22
MEDIVATION FIELD SOLUTIONS LLC
$21
Servier Pharmaceuticals LLC
$19
TAIHO ONCOLOGY, INC.
$18
Novocure Inc.
$18
Blueprint Medicines Corporation
$17
EUSA Pharma (US) LLC
$15
EKOS Corporation
$15
TG THERAPEUTICS, INC.
$15
TG Therapeutics, Inc.
$15
Sirtex Medical Inc
$15
Immunomedics, Inc.
$14
Myriad Genetic Laboratories, Inc.
$14
SANOFI-AVENTIS U.S. LLC
$14
Octapharma USA, Inc.
$13
Spectrum Pharmaceuticals Inc.
$13
Jazz Pharmaceuticals Inc.
$12
Boston Scientific Corporation
$12
Acrotech Biopharma LLC
$11
Medtronic USA, Inc.
$11
Veracyte, Inc.
$1
Top 3 companies account for 23.1% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BENDEKA · BESREMI · BEVYXXA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · Certus 140 · Creon · DARZALEX · DOPTELET · Doptelet · EKOSONIC · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Erleada · FLOWTRIEVER CATHETER · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · GammaTile · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LINZESS · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · Marqibo · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLAVIX · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · ROZLYTREK · RYBREVANT · Revlimid · Rezlidhia · Rubraca · S · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNCHROMED · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TIBSOVO · TIVDAK · TRULICITY · TUKYSA · Tarceva · Tavalisse · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Varithena Administration Pack · Venclexta · Vonjo · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZEVALIN · ZOLADEX · Zevalin · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for internal medicine in FL.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Internal Medicines within 10 mi
463
Per 100K population
103.1
County median income
$80,633
Nearest hospital
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kayali is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and high industry engagement (low-engagement, top 3%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kayali experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Kayali performed 99,450 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kayali receive payments from pharmaceutical companies?
Yes. Dr. Kayali received a total of $21,656 from 105 companies across 918 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kayali's costs compare to other internal medicines in Sarasota?
Dr. Kayali's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kayali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicines in Sarasota
Browse internal medicines in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicines in FL
Internal Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicines in FL
Which FL internal medicines receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc..
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc..
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology